Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5e95156255d5fe8b2923c544786e176 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-143333 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-347 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2264 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
filingDate |
2007-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c0294ccc45c59e8b0329ec54a72e376 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_590183e1a089a15816a24d18651a9c25 |
publicationDate |
2010-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2010056445-A1 |
titleOfInvention |
Adiponectin for the treatment and diagnosis of albuminuria |
abstract |
Disclosed are methods relating to the treatment and/or prevention of kidney disorders, especially kidney disorders characterized by or involving albuminuria. Methods described include the administration of an adiponectin polypeptide or a nucleic acid encoding such a polypeptide to treat or prevent the development of albuminuria. Also described are methods in which adiponectin is measured as a predictor of a subject's likelihood of having or developing a kidney disorder characterized by or involving albuminuria. Also described are methods of treating or preventing a kidney disorder involving administering an AMPK agonist and/or an inhibitor of Nox4 activity. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10526649-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10317321-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10995361-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018157048-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018080088-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11408890-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10563257-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2014034168-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11180804-B2 |
priorityDate |
2006-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |